Colombo et al. found that patients with CPA show impaired IFN-γ production in peripheral blood in response to stimuli, and immunotherapy with IFN-γ could be beneficial for those patients (13), which was consistent with what Kelleher et al. shared before (14). This evidence concerns the gene IFNG and congenital primary aphakia.